スタッフ ログイン
Japanese |
English
ご質問・ご要望
一覧
検索
生物種別閲覧
登録
統計情報
検索
ホーム
一覧
論文
特許
論文 - 一覧
«
»
50 Hits
検索条件 : 絞込み (MeSH = Antineoplastic Combined Chemotherapy Protocols / pharmacology*)
生物種
リソース名
RRC ID
タイトル
ジャーナル
公開日
外部リンク
ヒト・動物細胞
MKN7
,
MKN45(RCB1001)
80037
Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
Ann Surg Oncol
2013-3-1
Pubmed
Full text
ヒト・動物細胞
TE-1(RCB1894)
71967
The Mechanism of the Synergistic Anticancer Effect of CDDP and EPA in the TE1 Cell Line.
Anticancer Res
2021-4-1
Pubmed
Full text
ヒト・動物細胞
HuCCT1(RCB1960)
69598
Histone deacetylase inhibitor enhances the anti-tumor effect of gemcitabine: a special reference to gene-expression microarray analysis.
Oncol Rep
2011-11-1
Pubmed
Full text
ヒト・動物細胞
TGBC1TKB(RCB1129)
,
TGBC2TKB(RCB1130)
69443
Guggulsterone enhances antitumor activity of gemcitabine in gallbladder cancer cells through suppression of NF-κB.
J Cancer Res Clin Oncol
2012-10-1
Pubmed
Full text
ヒト・動物細胞
HMV-II(RCB0777)
69335
Combined inhibition of NF-κB and Bcl-2 triggers synergistic reduction of viability and induces apoptosis in melanoma cells.
Oncol Res
2013-1-1
Pubmed
Full text
ヒト・動物細胞
T24(RCB0431)
69238
Apoptosis of bladder cancer by sodium butyrate and cisplatin.
J Infect Chemother
2012-6-1
Pubmed
Full text
ヒト・動物細胞
PC-9(RCB4455)
67813
Favorable effect of the combination of vinorelbine and dihydropyrimidine dehydrogenase‑inhibitory fluoropyrimidine in EGFR‑mutated lung adenocarcinoma: retrospective and in vitro studies.
Int J Oncol
2015-3-1
Pubmed
Full text
ヒト・動物細胞
HuH-7
67738
HMDB and 5-AzadC Combination Reverses Tumor Suppressor CCAAT/Enhancer-Binding Protein Delta to Strengthen the Death of Liver Cancer Cells.
Mol Cancer Ther
2015-11-1
Pubmed
Full text
ヒト・動物細胞
HSC-2(RCB1945)
67145
ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinoma.
Oncogene
2018-1-18
Pubmed
Full text
ヒト・動物細胞
StromaNKtert(RCB2350)
66853
AMG-176, an Mcl-1 Antagonist, Shows Preclinical Efficacy in Chronic Lymphocytic Leukemia.
Clin Cancer Res
2020-7-15
Pubmed
Full text
ヒト・動物細胞
A549(RCB0098)
66056
Interleukin-6 blockade attenuates lung cancer tissue construction integrated by cancer stem cells.
Sci Rep
2017-9-26
Pubmed
Full text
ヒト・動物細胞
HCE-T(RCB2280)
65484
Venetoclax-based Rational Combinations are Effective in Models of
MYCN
-amplified Neuroblastoma.
Mol Cancer Ther
2021-8-1
Pubmed
Full text
ヒト・動物細胞
KGN(RCB1154)
65136
Systematic drug sensitivity testing reveals synergistic growth inhibition by dasatinib or mTOR inhibitors with paclitaxel in ovarian granulosa cell tumor cells.
Gynecol Oncol
2017-3-1
Pubmed
Full text
ヒト・動物細胞
HuCCT1(RCB1960)
,
TFK-1(RCB2537)
64967
Therapeutic implication of HER2 in advanced biliary tract cancer.
Oncotarget
2016-9-6
Pubmed
Full text
ヒト・動物細胞
LM8(RCB1450)
63904
Bempegaldesleukin (BEMPEG; NKTR-214) efficacy as a single agent and in combination with checkpoint-inhibitor therapy in mouse models of osteosarcoma.
Int J Cancer
2021-4-15
Pubmed
Full text
ヒト・動物細胞
CACO-2(RCB0988)
63862
Perifosine enhances the potential antitumor effect of 5-fluorourasil and oxaliplatin in colon cancer cells harboring the PIK3CA mutation.
Eur J Pharmacol
2021-5-5
Pubmed
Full text
ヒト・動物細胞
RBE(RCB1292)
,
TFK-1(RCB2537)
63822
Evaluation of NUC-1031: a first-in-class ProTide in biliary tract cancer.
Cancer Chemother Pharmacol
2020-6-1
Pubmed
Full text
ヒト・動物細胞
StromaNKtert(RCB2350)
63734
BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia.
Blood
2021-6-24
Pubmed
Full text
ヒト・動物細胞
JHOM-1(RCB1676)
,
JHOM-2B(RCB1682)
,
OMC-3(RCB0755)
63515
Synergistic antitumor effects of combination PI3K/mTOR and MEK inhibition (SAR245409 and pimasertib) in mucinous ovarian carcinoma cells by fluorescence resonance energy transfer imaging.
Oncotarget
2016-5-17
Pubmed
Full text
ヒト・動物細胞
Jurkat(RCB0806)
63156
Selective Targeting of Cancerous Mitochondria and Suppression of Tumor Growth Using Redox-Active Treatment Adjuvant.
Oxid Med Cell Longev
2020-1-1
Pubmed
Full text